Browse by author
Lookup NU author(s): Dr Louise Hyslop, Professor Lyle Armstrong, Professor Miodrag Stojkovic, Professor Majlinda LakoORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Embryonic stem cells (ESCs) are derived from the inner cell mass of the preimplantation stage embryo and are capable of prolonged symmetrical self-renewal (both daughter cells remain ESCs) as well as differentiation into derivatives of all three embryonic germ layers. ESCs therefore have the potential to provide an unlimited supply of transplantable cells to replace or regenerate damaged or diseased tissues. However, several barriers must be overcome before successful clinical trials are possible: for example, pure populations of the desired cell type need to be selected and expanded in clinically relevant numbers, and a method for preventing immunological rejection of the transplanted cells without long-term immunosuppressive therapy is also required. In this review, we highlight recent developments in human ESC derivation and expansion, outline current understanding of the signalling pathways underlying stem cell renewal, and discuss challenging problems related to the selective differentiation and immune properties of human ESCs. © 2005 Cambridge University Press.
Author(s): Hyslop LA, Armstrong L, Stojkovic M, Lako M
Publication type: Review
Publication status: Published
Journal: Expert Reviews in Molecular Medicine
Year: 2005
Volume: 7
Issue: 19
Pages: 1-21
ISSN (print): 1462-3994
ISSN (electronic):
URL: http://dx.doi.org/10.1017/S1462399405009804
DOI: 10.1017/S1462399405009804
PubMed id: 16171533
